Stock Message Board http://investorshangout.com/search?q=RHHBY&am...mp;yt1=Go!
Last Updated: 07/22/2014 03:00:44
Current Price and Quotes
Last Price 36.72
Previous Close 36.67 Open 36.70
Daily Range N/A - 36.75 52wk Range 30.48 - 38.71
Volume 1,302,184 Dividend 0.70
Average Vol (3m) 827,777 Yield 1.9
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 54,660,000 51,832,000 47,175,000 52,749,000
Cost of Revenue 13,435,000 13,301,000 12,771,000 14,261,000
Gross Profit 41,226,000 38,531,000 34,404,000 38,487,000
Operating Expenses
Research and Development 10,423,000 10,435,000 8,904,000 10,756,000
Sales, General and Admin. 12,389,000 12,664,000 11,112,000 13,263,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 18,413,000 15,431,000 14,388,000 14,468,000
Income From Continuing Operations
Add'l Income/Expense Items (134,000) (47,000) 692,000 598,000
Earnings Before Interest and Tax 18,280,000 15,384,000 15,093,000 15,063,000
Interest Expense 1,777,000 2,101,000 2,383,000 3,035,000
Earnings Before Tax 16,503,000 13,283,000 12,710,000 12,028,000
Income Tax 3,715,000 2,730,000 2,503,000 2,489,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - 13,000 (3,000)
Net Income Cont. Operations 12,788,000 10,553,000 10,219,000 9,535,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 12,788,000 10,553,000 10,206,000 9,539,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 12,788,000 10,553,000 10,206,000 9,539,000
Recent News
Jul 22, 2014 FDA Grants Genentech's Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Jul 15, 2014 FDA Grants Genentech's Avastin Priority Review for Certain Types of Cervical Cancer
Jul 14, 2014 Genentech's Investigational Medicine Cobimetinib, Used in Combination with Zelboraf(R) (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening
Jul 2, 2014 Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals
Jul 2, 2014 Seragon Pharmaceuticals Announces Acquisition Agreement With Genentech
Jun 10, 2014 Health Canada Approves Roche's HPV Test for First-Line Primary Screening of Cervical Cancer and Roche Launches New Cytology Test to Provide the Most Comprehensive Portfolio for Cervical Cancer Screening
Jun 8, 2014 2018 Medical Automation Industry Forecasts in North America, Europe, Asia & ROW Analysis Now at ReportsnReports.com
May 31, 2014 Investigational Immunotherapy Anti-PDL1 (MPDL3280A) Shrank Tumors in 43 Percent of People with a Specific Type of Metastatic Bladder Cancer in a Genentech Study
May 20, 2014 Roche Diagnostics recognizes Pathology, Inc as Roche Molecular Center of Excellence
May 15, 2014 Exosomes Common Link in Cancer Drug Development
1
2
next >
RHHBY Roche Holding Ltd Research DD Guide
Stock Message Board http://investorshangout.com/search?q=RHHBY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/RHHBY/quote
Stock Chart http://www.otcmarkets.com/stock/RHHBY/chart
Company Info http://www.otcmarkets.com/stock/RHHBY/company-info
Recent News http://www.otcmarkets.com/stock/RHHBY/news
Financials http://www.otcmarkets.com/stock/RHHBY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/RHHBY/filings
Short Sales http://www.otcmarkets.com/stock/RHHBY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/RHHBY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/RHHBY/research
Summary http://finance.yahoo.com/q?s=RHHBY
Historical Prices http://finance.yahoo.com/q/hp?s=RHHBY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=RHHBY
Basic Chart http://finance.yahoo.com/q/bc?s=RHHBY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=RHHBY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=RHHBY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=RHHBY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=RHHBY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=RHHBY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=RHHBY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=RHHBY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=RHHBY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=RHHBY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=RHHBY
Balance Sheet http://finance.yahoo.com/q/bs?s=RHHBY
Cash Flow http://finance.yahoo.com/q/cf?s=RHHBY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/RHHBY
Market Watch http://www.marketwatch.com/investing/stock/RHHBY
Bloomberg http://www.bloomberg.com/quote/RHHBY:US
Morningstar http://quotes.morningstar.com/stock/s?t=RHHBY
Bussinessweek http://investing.businessweek.com/research/st...cker=RHHBY
Barchart http://www.barchart.com/quotes/stocks/RHHBY
OTC Short Report http://otcshortreport.com/index.php?index=RHHBY
Investopedia http://www.investopedia.com/markets/stocks/RHHBY/?wa=0